CN Patent

CN113423383A — Pth缀合物的液体药物制剂

Assigned to Ascendis Pharma Bone Diseases AS · Expires 2021-09-21 · 5y expired

What this patent protects

液体药物制剂，其中所述药物制剂包含PTH缀合物、缓冲剂、等渗剂、防腐剂和任选的抗氧化剂，并且其中所述PTH缀合物包含与水溶性载体部分共价和可逆地缀合的PTH部分。

USPTO Abstract

液体药物制剂，其中所述药物制剂包含PTH缀合物、缓冲剂、等渗剂、防腐剂和任选的抗氧化剂，并且其中所述PTH缀合物包含与水溶性载体部分共价和可逆地缀合的PTH部分。

Drugs covered by this patent

Patent Metadata

Patent number
CN113423383A
Jurisdiction
CN
Classification
—
Expires
2021-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Ascendis Pharma Bone Diseases AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.